Research Article |
Corresponding author: Huynh Nhu Mai ( mhnhu@ump.edu.vn ) Academic editor: Magdalena Kondeva-Burdina
© 2024 Duyen Thi My Huynh, Linh My Le, Lam Thanh Nguyen, Trung Ho Nhan Nguyen, Minh Hoang Nguyen, Khang Tran Vinh Nguyen, Khanh Quoc Tran, Trung Le Quoc Tran, Minh-Ngoc Thi Le, Huynh Nhu Mai.
This is an open access article distributed under the terms of the Creative Commons Attribution License (CC BY 4.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Citation:
Huynh DTM, Le LM, Nguyen LT, Nhan Nguyen TH, Nguyen MH, Vinh Nguyen KT, Tran KQ, Quoc Tran TL, Thi Le M-N, Mai HN (2024) Investigation of acute, sub-chronic toxicity, effects of mangiferin and mangiferin solid dispersion (HPTR) on Triton WR1339-induced hyperlipidemia on Swiss albino mice. Pharmacia 71: 1-14. https://doi.org/10.3897/pharmacia.71.e123277
|
Mangiferin is a xanthonoid found in Mango leaves in abundance with many effects as a hypoglycemic, antioxidant, and anti-inflammatory agent, plant metabolite, and so on. However, nowadays, mango leaves are merely a waste product in Vietnam. To take advantage of this valuable medicinal resource, extraction conditions of mangiferin using classical and ultrasound methods were researched, and mangiferin was purified from Cat Chu mango leaves (Mangifera indica L., Anacardiaceae) collected in Dong Thap. Ultrasound-assisted extraction method was conducted with the following conditions and mangiferin was extracted at a percentage of 6.728% with a purity of 91.11%. Purified mangiferin was evaluated using molecular absorption spectroscopy UV-Vis, scanning electron microscopy (SEM), X-ray diffraction (XRD) spectroscopy, simultaneous thermal analysis (STA: TGA/DSC), and dissolution measurement method. To optimize the solubility and permeability of mangiferin, the solid dispersion system (HPTR) was made by the combination of HPMC 6M:mangiferin at the ratio of 1:5. To investigate the acute, sub-chronic toxicity and hypolipidemia effect of HPTR as compared to purified mangiferin, we followed guidelines for preclinical and clinical trials of Traditional Medicine and Herbal Medicines by the Vietnam Ministry of Health and OECD, and used tyloxapol (Triton WR1339, 400 mg/kg, i.p.) to induce hyperlipidemia. Our results indicated that purified mangiferin and HPTR extract showed no acute toxicity and sub-chronic toxicity and has potential as an antihyperlipidemic agent. The HPTR brought about a significant decrease in total cholesterol, triglycerides and LDL-c when compared to mangiferin, however there was no significance between them.
Cat Chu mango leaves, cholesterol, HPTR, mangiferin, tyloxapol, xanthone glycoside
In recent years, the use of medicinal herbs has been increasing. Vietnam is a country with a wide diversity of climate and soil, which results in a wealth of biological resources including many plant species with high medicinal value (
Currently, Mango is mainly grown as a fruit-bearing tree. Other parts of Mango, especially the leaves, are merely by-products and often discarded during the growing process. According to many studies, Mango leaves contain many active ingredients such as mangiferin (MGF). MGF is a xanthone glycoside proved to have many pharmacological effects including antidiabetic, lipometabolism regulating, anti-cancer, antioxidant, anti-herpes virus, etc (
Mangiferin is a C-glucosyl xanthone, which has been shown to have many pharmacological effects including antidiabetic, antitumor, lipometabolism-regulating, antioxidant, analgesic, antibacterial, antiviral, and immunomodulatory effects (
Cat Chu mango leaves (Mangifera indica L., Anacardiaceae) that were dark green and thick without pests, damage, and termites were harvested in November 2022 in Cao Lanh, Dong Thap. After being harvested, the leaves were washed and dried at 50–60 °C until the weight remained. Then they were ground and sieved into crude powder that was stored in a sealed package away from moisture.
The research was conducted at the Department of Pharmaceutics and Pharmaceutical Technology, Faculty of Pharmacy, Can Tho University of Medicine and Pharmacy and at the Central Laboratory for Analysis, Ho Chi Minh City University of Science.
Approximately 10 g of dried mango leaf medicinal powder (A) was weighed and put in a conical flask with a stopper. Ethanol (B) was added according to a ratio of (C), then water bath extraction was conducted at a room temperature of (D) for (E) hours (Table
Survey of extraction conditions using classical and ultrasonic extraction methods.
No | Classical extraction | Ultrasonic extraction | ||||||||
---|---|---|---|---|---|---|---|---|---|---|
Symbol | Ethanol concentration (%) (B) | Ratio of herbs/ solvent (C) | Temperature (D) (Turner et al.) | Extraction time (E) (hour) | Symbol | Ethanol concentration (%) (F) | Ratio of herbs/ solvent (G) | Ultrasound time (H) (minutes) | Amplitude of ultrasonic waves (M) (%) | |
1 | B1 | 50 | 1/12 | Room temperature | 9 | F1 | 50 | 1/12 | 15 | 70 |
2 | B2 | 60 | 1/12 | Room temperature | 9 | F2 | 60 | 1/12 | 15 | 70 |
3 | B3 | 70 | 1/12 | Room temperature | 9 | F3 | 70 | 1/12 | 15 | 70 |
4 | B4 | 80 | 1/12 | Room temperature | 9 | F4 | 80 | 1/12 | 15 | 70 |
5 | C1 | B | 1/10 | Room temperature | 9 | G1 | F | 1/10 | 15 | 70 |
6 | C2 | B | 1/12 | Room temperature | 9 | G2 | F | 1/12 | 15 | 70 |
7 | C3 | B | 1/15 | Room temperature | 9 | G3 | F | 1/15 | 15 | 70 |
8 | C4 | B | 1/17 | Room temperature | 9 | G4 | F | 1/17 | 15 | 70 |
9 | D1 | B | C | Room temperature | 9 | H1 | F | G | 5 | 70 |
10 | D2 | B | C | 40 | 9 | H2 | F | G | 10 | 70 |
11 | D3 | B | C | 50 | 9 | H3 | F | G | 15 | 70 |
12 | D4 | B | C | 60 | 9 | H4 | F | G | 20 | 70 |
13 | E1 | B | C | D | 6 | M1 | F | G | H | 60 |
14 | E2 | B | C | D | 9 | M2 | F | G | H | 70 |
15 | E3 | B | C | D | 18 | M3 | F | G | H | 80 |
16 | E4 | B | C | D | 24 | M4 | F | G | H | 90 |
Approximately 10 g of dried mango leaf medicinal powder (A) was weighed and put in a conical flask with a stopper. Ethanol (F) was added according to a ratio of (G), then extraction with ultrasound was conducted at a normal temperature for (H) minutes with an amplitude of (M) (Table
Mangiferin content was evaluated using molecular absorption spectroscopy UV-Vis (this study referred to the research by Nguyen Thi Truc Loan (
The crude extract efficiency obtained was calculated according to the following formula:
(Eq. 1)
m was the weight of the concentrated extract obtained (g); n was the moisture content of the extract (%).
The mangiferin content in the extracted sample was worked out using the following formula (
(Eq. 2)
c was the value of the mangiferin standard curve (mg); V was the volume of the extract solution (mL); m was the weight of extract in the volume (g/mL); n was the moisture content of the extract (%); H was the extract efficiency (%).
240 g of medicinal powder was taken to extract with the best extraction conditions surveyed above, and then purification of mangiferin was investigated as follows:
The crude extract and distilled water were mixed at a ratio of 1:2 (v/v). The liquid-liquid extraction was surveyed with a solution containing mangiferin with each solvent including n-butanol, chloroform, benzene, and ethyl acetate at a ratio of 1:1 (v/v). The lower layer was taken. It was left for about 24 hours for the crystallization of mangiferin, then it was filtered and dried at 50 °C to a moisture content < 5% (
Each sample was repeated 3 times to take the average result. The efficiency of purified mangiferin obtained was calculated as the following formula:
(Eq. 3)
M was the purified mangiferin weight obtained; N was the moisture content of mangiferin.
The purity of the mangiferin obtained was compared to the standard mangiferin and worked out as follows (
(Eq. 4)
C1, A1: concentration and absorbance of standard mangiferin; C2, A2: concentration and absorbance of purified mangiferin obtained.
Appearance: the sample was observed with the naked eye under natural light, and then compared with the data in Vietnamese Pharmacopoeia V (
UV-VIS spectrum measurement: the spectrum of the purified mangiferin was compared to the standard by UV-Vis from wavelength 200 nm to 600 nm.
Particle size: the sample was observed using scanning electron microscope (SEM). The test was conducted on a scanning electron microscope JSM-IT 200 (Jeol, Japan). The sample was coated with platinum before analysis with carbon glue to adhere the sample to the copper substrate and a voltage of 10 kV.
Crystal structure: the sample was observed using X-ray diffraction (XRD) spectroscopy. The test was conducted on a D8 Advance Eco device (Bruker, Germany) at a voltage of 40 kV, an amperage of 25 mA, a Cu K-alpha wavelength of 0.154 nm, a step size of 0.02°, and a step time of 0.1s.
Hydration: the experiment was conducted on PT 1600 equipment (Linseis, Germany) by thermal gravimetric analysis (STA: TGA/DSC). The sample was weighed on a 5-digit weighing device (OHAUS Explorer125, USA) in an alumina crucible and stabilized in the analysis chamber for 10 minutes before the test. The air flow rate was 4 L/hour. It depended on the situation that an inert gas (Argon) or a dry air (DryAir: N2/O2 ratio 4:1) would be used. The heating rate was 10 °C/ minute.
Dissolution: dissolution was measured by a paddle-type dissolution apparatus Pharmatest PTWS 120D with a rotation speed of 100 rpm at a temperature of 37 ± 0.5 °C. 500 mL of a pH 1.2 dissolution medium (buffer solution was prepared according to section 2.3 of Appendix 2 in Vietnamese Pharmacopoeia V). 80 mg of mangiferin sample was added into the dissolution medium. After 5, 15, 30, 45, and 60 minutes, 10 mL of solution was drawn and filtered through filter papers. 1 mL of the filtrate was drawn and put into a 10 mL volumetric flask, and then a pH 1.2 buffer was added to fit the volume. Absorbance was measured by using molecular absorption spectroscopy UV-VIS at a wavelength of 258 nm.
The blank sample was a pH 1.2 buffer. Each sample was tested 3 times to get the average result. Uncorrected mangiferin concentration at the nth time was calculated as follows:
(Eq. 5)
Cn was the corrected concentration at the nth time (µg/mL); Cn0 was the uncorrected concentration at the nth time (µg/mL); Cn-1 was the corrected concentration at the (n-1)th time (µg/mL); Vo was the volume of the solution withdrawn (Vo = 10 mL); V was the volume of the dissolution medium (V = 500 mL).
The percentage of dissolved mangiferin at the time t was calculated according to the formula:
(Eq. 6)
n was the corrected concentration at the nth time (µg/mL); m was the mangiferin content in the sample (mg).
The percentage of dissolved purified mangiferin at the time t was calculated and compared with the dissolution of the control mangiferin according to the independent model with the similarity factor f2:
(Eq. 7)
n was the number of times of sampling R; Rt was the dissolution of the reference substance at the time t; Tt was the dissolution of the test substance at the time t; 0 < f2 < 50: two lines represented different dissolution profiles.
The mangiferin solid dispersion system combined with HPMC 6M at the ratio of 1:5 ratio to make the preparation helped improved the solubility of the mangiferin solid dispersion system.
All animals were treated in accordance with the Institute for Laboratory Animal Research (ILAR) Guidelines for the Care and Use of Laboratory Animals (
Eight-week-old Swiss albino mice in both sexes were obtained from Pasteur Institute, Ho Chi Minh City, Vietnam, each weighing approximately 20–25 g. Then, they were randomized, and housed in a temperature-controlled animal facility (24 ± 2 °C) and fed ad libitum. Mice were maintained for at least 7 days before starting the experiments.
Female and male mice were used for the acute and sub-chronic oral toxicity tests. 16 mice (8 males and 8 females) were used in an acute oral toxicity test, whereas 24 mice (12 males and 12 females) were used in sub-chronic oral toxicity test (the repeated dose 28 day). The toxicity tests were carried out according to the Guidelines for preclinical and clinical trials of Traditional Medicine and Herbal Medicines by the Vietnam Ministry of Health (
24 mice were randomly divided into three groups of 8 mice each (n = 8/group, 4 males and 4 females) as mentioned elsewhere (
Group 1 received distilled water and served as control.
Groups 2, and 3 received HPTR 200 mg/kg and mangiferin 200 mg/kg body weight, respectively.
Mice were observed for 28 days and anesthetized following a 12-hour fast. Blood samples were drawn from the heart into a vacuum tube, and organs (liver, kidneys) were collected for hematoxylin and eosin staining. Mortality and general toxicity signs of the animals were monitored and recorded daily throughout the study. The body weight of all the groups had been recorded before treatment and at the end of each week (
Mice received a single dose of tyloxapol (Triton WR1339) [400 mg/kg, intraperitoneal injection (i.p.); T0307, Sigma-Aldrich, MO, USA] (
Blood samples were kept in K2EDTA tube for analyzing hematological parameters [red blood cell (RBC), hemoglobin (Hb), white blood cell (WBC), mean corpuscular hemoglobin (MCH), platelet (PLT), mean corpuscular volume (MCV), hematocrit (HCT)] and in plain tubes for biochemical parameters [urea, creatinine, alanine aminotransferase (
Livers and kidneys were collected and fixed by overnight immersion in 10% buffered formalin. According to a standard protocol, paraffin-embedded specimens were prepared, and 5.0 μm sections were stained with H&E (Sigma-Aldrich, St. Louis, MO, USA). Hepatic pathology was assessed with an Olympus BX40 microscope by an investigator who was blinded to the experimental treatment groups (
The measurement procedure was conducted following the manufacturer’s protocol [Cholesterol (03039773190, Cobas, Germany), Triglyceride (20767107322, Cobas, Germany), HDL-c (07528566190, Cobas, Germany), LDL-c (07005717190, Cobas, Germany), Creatinine (04810716190, Cobas, Germany), Urea (04460715190, Cobas, Germany), ALT (20764957322, Cobas, Germany), and AST (20764949322, Cobas, Germany)].
Statistical analyses were performed using IBM SPSS 20 software. One-way analysis of variance (ANOVAs) was used to examine the main effects. To determine specific group differences in case of significant main effects, the one-way ANOVA was followed by Tukey post-hoc test. P-values of less than 0.05 were deemed to indicate statistical significance.
The results of extraction efficiency and mangiferin content obtained under different conditions are presented in Tables
Extraction efficiency and mangiferin content obtained by the classical extraction method.
Formula | B1 | B2 | B3 | B4 | C1 | C2 | C3 | C4 | D1 | D2 | D3 | D4 | E1 | E2 | E3 | E4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1st H% | 4.65 | 4.48 | 4.46 | 4.40 | 4.74 | 4.73 | 4.77 | 4.68 | 4.70 | 4.61 | 4.71 | 4.74 | 4.72 | 4.70 | 4.81 | 4.67 |
2nd H% | 4.49 | 4.67 | 4.44 | 4.58 | 4.57 | 4.64 | 4.58 | 4.58 | 4.82 | 4.71 | 4.72 | 4.70 | 4.75 | 4.82 | 4.83 | 4.78 |
3rd H% | 4.44 | 4.52 | 4.65 | 4.54 | 4.53 | 4.52 | 4.58 | 4.63 | 4.58 | 4.81 | 4.72 | 4.78 | 4.78 | 4.76 | 4.67 | 4.89 |
Average H% | 4.53 | 4.56 | 4.52 | 4.51 | 4.61 | 4.63 | 4.64 | 4.63 | 4.70 | 4.71 | 4.72 | 4.74 | 4.75 | 4.76 | 4.77 | 4.78 |
RSD | 2.48 | 2.23 | 2.63 | 2.10 | 2.52 | 2.20 | 2.43 | 1.02 | 2.53 | 2.17 | 0.11 | 0.78 | 0.63 | 1.30 | 1.82 | 2.32 |
X 1 | 9.60 | 11.1 | 8.99 | 8.47 | 8.37 | 11.12 | 12.52 | 10.18 | 12.93 | 19.75 | 21.12 | 22.62 | 20.52 | 23.25 | 23.93 | 24.24 |
X 2 | 9.65 | 10.3 | 8.76 | 8.67 | 8.37 | 11.44 | 12.78 | 10.39 | 12.75 | 19.22 | 21.83 | 22.96 | 20.34 | 23.79 | 23.05 | 23.45 |
X 3 | 9.27 | 10.9 | 8.91 | 8.57 | 8.04 | 11.25 | 13.16 | 10.62 | 13.27 | 20.13 | 20.81 | 23.77 | 19.73 | 22.58 | 23.95 | 24.72 |
Average X | 9.51 | 11.1 | 8.89 | 8.57 | 8.26 | 11.27 | 12.82 | 10.40 | 12.98 | 19.70 | 21.25 | 23.12 | 20.20 | 23.21 | 23.64 | 24.14 |
RSD | 2.21 | 2.04 | 1.33 | 3.50 | 2.33 | 2.49 | 2.51 | 2.12 | 2.03 | 2.32 | 2.46 | 2.56 | 2.05 | 2.61 | 2.17 | 2.66 |
Extraction efficiency and mangiferin content obtained by ultrasonic extraction method.
Formula | F1 | F2 | F3 | F4 | G1 | G2 | G3 | G4 | H1 | H2 | H3 | H4 | M1 | M2 | M3 | M4 |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
1st H% | 6.12 | 6.32 | 6.28 | 6.25 | 6.08 | 6.26 | 6.21 | 6.04 | 6.12 | 6.38 | 6.24 | 6.14 | 6.28 | 6.22 | 6.37 | 6.16 |
2nd H% | 6.18 | 6.10 | 6.24 | 5.97 | 6.11 | 6.26 | 6.25 | 6.37 | 6.41 | 6.18 | 6.23 | 6.42 | 6.38 | 6.37 | 6.47 | 6.45 |
3rd H% | 5.97 | 6.02 | 6.05 | 6.26 | 6.27 | 5.98 | 6.17 | 6.22 | 6.25 | 6.23 | 6.35 | 6.26 | 6.21 | 6.24 | 6.14 | 6.32 |
Average H% | 6.09 | 6.15 | 6.19 | 6.16 | 6.15 | 6.16 | 6.21 | 6.21 | 6.26 | 6.26 | 6.27 | 6.27 | 6.28 | 6.28 | 6.33 | 6.31 |
RSD | 1.82 | 2.49 | 2.03 | 2.63 | 1.47 | 2.61 | 0.69 | 2.61 | 2.32 | 1.68 | 1.05 | 2.26 | 0.99 | 1.29 | 2.67 | 2.27 |
X 1 | 31.41 | 31.31 | 33.78 | 31.18 | 28.01 | 33.23 | 35.02 | 34.03 | 29.72 | 31.75 | 34.96 | 37.51 | 33.31 | 37.62 | 34.99 | 35.69 |
X 2 | 30.44 | 31.71 | 34.76 | 32.86 | 27.06 | 33.26 | 36.06 | 35.22 | 30.36 | 33.34 | 33.76 | 37.09 | 33.79 | 37.02 | 35.78 | 35.51 |
X 3 | 30.14 | 32.26 | 33.17 | 31.82 | 28.15 | 34.75 | 36.86 | 34.30 | 28.78 | 32.06 | 34.31 | 38.49 | 34.73 | 38.55 | 34.43 | 34.03 |
Average X | 30.66 | 31.76 | 33.90 | 31.95 | 27.74 | 33.75 | 35.98 | 34.52 | 29.62 | 32.38 | 34.35 | 37.70 | 33.94 | 37.73 | 35.07 | 35.08 |
RSD | 2.17 | 1.50 | 2.37 | 2.65 | 2.14 | 2.58 | 2.56 | 1.81 | 2.68 | 2.60 | 1.75 | 1.91 | 2.13 | 2.04 | 1.93 | 2.60 |
The mangiferin content obtained was the most optimal using the ultrasound-assisted extraction method with the following parameters: ethanol 70% (F3), medicinal material/solvent ratio of 1/15 (G3), ultrasound time of 20 minutes (H4), and ultrasound amplitude of 70% (M2).
The comparison of E2 and M2 formulas showed that the efficiency and mangiferin content obtained by the ultrasonic extraction method were higher than by the classical extraction one.Purification of mangiferin
When ethyl acetate was used, many impurities were removed with the highest purity of 91.11% (Table
Extraction efficiency and purity of mangiferin obtained after purification.
Solution | N-butanol | Chloroform | Benzene | Ethyl acetate |
---|---|---|---|---|
1st H% | 3.028 | 4.335 | 2.210 | 2.234 |
2nd H% | 3.154 | 4.272 | 2.141 | 2.316 |
3rd H% | 3.126 | 4.205 | 2.255 | 2.294 |
Average H% | 3.103 | 4.271 | 2.202 | 2.281 |
RSD | 2.125 | 2.609 | 1.512 | 1.860 |
1st purity | 30.25 | 25.89 | 36.69 | 91.07 |
2nd purity | 31.34 | 27.12 | 38.30 | 91.21 |
3rd purity | 31.63 | 26.55 | 37.55 | 91.05 |
Average purity | 31.07 | 26.52 | 37.51 | 91.11 |
RSD | 2.342 | 2.321 | 2.148 | 0.096 |
Appearance: the crystals were pale yellow, smooth, odorless, and consistent with the data in the Vietnamese Pharmacopoeia V (Fig.
UV-Vis spectrum measurement: the spectrum of the standard mangiferin and the purified mangiferin at the same concentration of 16 μg/mL were completely similar to the full absorption peaks in the Vietnamese Pharmacopoeia V (Fig.
Particle size: based on the results under the scanning electron microscope, both samples had similar particle sizes (Fig.
Crystal structure: X-ray powder diffraction results showed that both control mangiferin and purified mangiferin samples were crystalline. However, the purified sample had some additional peaks at positions of 6°–15°. The signal intensity of the purified mangiferin at the main peaks (positions of 10°–30°) was much lower than that of the control mangiferin, showing that the crystallinity of the purified mangiferin was lower (Fig.
Hydration: the moisture content of the control sample was about 2% while the figure for purified mangiferin was 8%. The evaporation of water from the surface took place in the reaction zone from 80 °C to 120 °C.
The number of water molecules in the structure of C19H18O11.xH2O was estimated. The amount of water in the structure was calculated based on the formula (18x)/(423 + 18x):
Dissolution: in the first 5 minutes, the dissolution of the purified mangiferin was greater than that of the control mangiferin. However, from 5 minutes onwards, there was a reverse. The level of active ingredient dissolution of both samples tended to increase over time and had a value of f2 = 50.17 (Fig.
Oral administration of HPTR and mangiferin showed no treatment-related mortality in both sexes of mice for both acute and sub-chronic oral toxicity tests throughout the study. Physical observation of the HPTR (4200 mg/kg, equivalent to mangiferin 700 mg/kg) and mangiferin treated mice for both acute (700 mg/kg) and sub-chronic oral toxicity tests (200 mg/kg) throughout this study indicated that none of them showed signs of toxic effects such as changes in weight, skin and fur, eyes and mucous membrane, behavior pattern, tremors, salivation, and coma. Diarrhea appeared at the rate of 12.5% (200 mg/kg mangiferin-treated group) in the 3rd week to 25% (200 mg/kg HPTR-treated group) in the first week in sub-chronic oral toxicity tests but mice recovered after several days. No mortality and other general toxicity signs of the animals were recorded throughout the study.
No macroscopic or microscopic pathological abnormalities in the livers and kidneys were observed in all groups, (700 mg/kg in acute oral toxicology test and 200 mg/kg in sub-chronic oral toxicity tests for 28 days). According to the Globally Harmonized Classification System, mangiferin and HPTR can be classified as Category 5 and this provides direct relevance for protecting animal’s health up to the high dosage used in those studies.
The hematological profile of control and HPTR/mangiferin treated groups is summarized in Table
Hematological parameters in sub-chronic oral toxicology of magiferin and HPTR. Red blood cell (RBC); Hemoglobin (Hb); Hematocrit (HCT); Mean corpuscular volume (MCV); Mean Corpuscular Hemoglobin (MCH); Platelet (PLT), and white blood cell (WBC). Comparison between the groups was made by one way analysis of variance (ANOVA) followed by a Tukey post-hoc test.
Parameters | Control | Mangiferin 200 mg/kg | HPTR 200 mg/kg |
---|---|---|---|
RBC (Tera/L) | 8.68 ± 0.52 | 9.89 ± 0.73 | 9.72 ± 0.667 |
Hb (g/dL) | 12.42 ± 0.62 | 14.17 ± 0.94 | 13.76 ± 2.18 |
HCT (%) | 39.55 ± 5.21 | 43.98 ± 3.21 | 43.6 ± 4.55 |
MCV (fL) | 48.33 ± 3.33 | 44.5 ± 2.12 | 44.82 ± 0.246 |
MCH (pg) | 14.67 ± 1.04 | 14.34 ± 0.62 | 14.12 ± 0.15 |
PLT (G/L) | 838.50 ± 136.85 | 711.28 ± 290.21 | 743 ± 69.195 |
WBC (G/L) | 8.38 ± 2.37 | 8.45 ± 0.46 | 11.5 ± 2.078 |
Biochemical parameters in sub-chronic oral toxicology of mangiferin and HPTR. Aspartate aminotransferase (AST); Alanine aminotransferase (ALT); urea, and creatinine. Comparison between the groups was made by one-way analysis of variance (ANOVA) followed by a Tukey post-hoc test.
Parameters | AST (U/L) | ALT (U/L) | Urea (mmol/L) | Creatinine (µmol/L) |
---|---|---|---|---|
Control | 84.33 ± 34.33 | 35.83 ± 7.73 | 4.72 ± 0.31 | 30.00 ± 2.48 |
Mangiferin 200 mg/kg | 97.57 ± 24.49 | 26.86 ± 4.81 | 4.56 ± 0.65 | 33.74 ± 8.89 |
HPTR 200 mg/kg | 87.00 ± 23.43 | 22.00 ± 2.00 | 3.87 ± 1.17 | 28.44 ± 1.98 |
The data on biochemical parameters in control and HPTR/mangiferin treated groups of sub-chronic oral toxicity tests are presented in Table
The photomicrographs of the liver and kidney of the control and HPTR/mangiferin treated groups, both male and female, showed normal morphological architecture. Similar to the control group, the liver of HPTR/mangiferin treated animals showed normal cellular architecture, binucleation and was without any distortions. Furthermore, signs of injury, necrosis, congestion, fatty acid accumulation, or hemorrhagic regions around the central vein or sinusoids of the liver were not observed (Fig.
For the kidneys, there were no morphological changes for HPTR/mangiferin treated groups. The appearance of the glomerular architecture showed normal structure which was similar to that of the control groups (Fig.
The total cholesterol (A), triglyceride (B), HDL-c (C) and LDL-c (D) levels of the control, tyloxapol, atorvastatin, mangiferin 200 mg/kg, and HPTR 200 mg/kg treated groups were demonstrated in Fig.
We observed a significant difference in total cholesterol level in mice injected with tyloxapol as compared with the control group (p < 0.05). In this study, mangiferin and HPTR at 200 mg/kg and atorvastatin groups reduced blood cholesterol significantly as compared to the tyloxapol group (p < 0.05). Specifically, HPTR at 200 mg/kg was as effective as atorvastatin in reducing cholesterol levels compared to the tyloxapol group (Fig.
Effect of Mangiferin and HPTR on lipid profile in serum of mice. A. Total cholesterol; B. Triglyceride; C. HDL-c and D. LDL-c. Comparison between the groups was made by one-way analysis of variance (ANOVA) followed by Tukey post-hoc test. *p < 0.01 vs. control group. #p < 0.05, ##p < 0.01 vs. Tyloxapol group.
We also observed a similar trend with the level of triglyceride in the tyloxapol injected group. A significant difference in triglyceride level was documented. A Tukey post-hoc test revealed significant pairwise differences between tyloxapol injected group and control group, with an increase of 25 times. Atorvastatin, mangiferin 200 mg/kg, and HPTR 200 mg/kg showed a decrease in triglyceride level (p < 0.05). Although both mangiferin 200 mg/kg, and HPTR 200 mg/kg resulted in lower triglyceride levels than atorvastatin group, no significant differences were found among these groups (Fig.
Hyperlipidemia is a metabolic disorder characterized by abnormal lipid metabolism and elevated levels of serum low-density lipoprotein cholesterol (LDL-c), triglycerides (TG), and total cholesterol (TC), as well as decreased levels of high-density lipoprotein cholesterol (HDL-c). Interestingly, while we found that HDL-c level was significantly decreased following the injection of tyloxapol (p < 0.01), neither atorvastatin nor mangiferin 200 mg/kg treated group showed any improvement of HDL-c level. Only HPTR 200 mg/kg showed a significant improvement in HDL-c level (Fig.
The LDL-c level showed that only mangiferin at a dose of 200 mg/kg was effective in reducing LDL-c, but this reduction was not statistically significant compared to the tyloxapol group (p > 0.05). HPTR 200 mg/kg and atorvastatin group also reduced LDL-c, and this reduction was significant compared to tyloxapol group (p < 0.05). HPTR 200 mg/kg was more effective in lowering LDL-c than mangiferin; this difference was not statistically significant (p > 0.05) (Fig.
As for the classical extraction method, the results showed that ethanol 60% brought about the best extraction efficiency. With a lower ethanol concentration, mangiferin extraction was not highly effective because mangiferin is poorly soluble in water. However, when the ethanol concentration was too high, the extraction efficiency was also low because the extraction time would be long which led to solvent evaporation, hence a reduction in efficiency. The results were consistent with the research by Nguyen Duc
With a low solvent content (1/10 and 1/12), extracting mangiferin became more difficult because the amount of solvent was not enough to extract all the mangiferin in mango leaves which led to a decrease in contact with raw materials and inefficiency. However, if the amount of solvent used was too much, the amount of impurities in the extract would increase, thus wasting raw materials and fuel. In this study, the amount of mangiferin increased when the amount of solvent went up to 1/15, but at a ratio of 1/17, it decreased clearly. These results were similar to the study by Nguyen Thi Truc Loan who extracted mangiferin from Acacia mango leaves. To be more specific, with a high solvent content, the results showed that the mangiferin content obtained using the classical extraction method was also low (
Temperature had an important effect on the extraction of mangiferin from Cat Chu mango leaves. This was due to the fact that at high temperature, the mass transfer occurred quickly which helped reduce viscosity and increase the solubility and diffusion of mangiferin. The extraction was conducted at normal temperature with water bath extraction at temperatures ranging from 40 °C to 60 °C (not at higher temperatures to limit the evaporation of alcohol). As a result, 60 °C was the most suitable temperature for the extraction of mangiferin using the classical extraction method. This outcome was similar to the research by Kulkarni VM et al. which surveyed extraction temperatures from 30 °C to 70 °C. The result showed that the efficiency gradually increased along with the rise in temperature from 30 °C to 60 °C and was most optimal at 60 °C (
The most optimal soaking time for extracting mangiferin using the classical extraction method was 9 hours. With a shorter soaking time (6 hours), the mangiferin extraction was not very effective because there was not enough time for mangiferin to dissolve and diffuse in the solvent. In this study, when the soaking time rose to 18 hours and 24 hours, the extraction efficiency did change much. This was similar to the fact that when the extraction time increased, the amount of mangiferin did not dissolve in the solvent. This result was completely consistent with the study by Pham Ngoc Khoi and Phung Thanh Son on the optimization of fish mint extraction. With a soaking time of 2 hours, the mangiferin extraction using Soxhlet method also achieved high results (
With the ultrasonic extraction method, ethanol 70% gave the highest efficiency and the most mangiferin content. This was the same as the result in Nguyen Thi Truc Loan’s research which illustrated that with lower ethanol concentration (< 70%), mangiferin content obtained after extraction using the ultrasound-assisted extraction method was also lower (
Similar to the survey of the ratio of plant/solvent in the classical extraction method, 1/15 was still the most optimal condition in the ultrasonic extraction method. Regarding the ultrasound time, 20 minutes was the optimal time for the mangiferin extraction using the ultrasonic extraction method. With lower ultrasound times (< 20 minutes), mangiferin extraction was not highly effective because the time was not enough to fully extract the amount of mangiferin in mango leaves, leading to low extraction efficiency. In addition, the results were also consistent with that of the study on mangiferin in mango leaves by Zou TB et al. which showed that extraction efficiency increased when increasing ultrasound time from 5 to 20 minutes, but then decreased when the time was longer than 20 minutes (
The optimal amplitude for ultrasonic extraction of mangiferin was ethanol 70%. When the amplitude increased to 80%, 90%, and 100%, the mangiferin content gradually decreased. The reason might be that the higher the amplitude was, the greater the decomposition of active ingredients was. At that time, there was a heat release which resulted in the evaporation of the solvent. The research by Nuttawan Yoswathana concluded that raising ultrasound amplitudes from 25% to 75% helped enhance the efficiency of xanthone extraction from dried Mangosteen fruit peel (
The subchronic toxicity test was conducted at a dosage of 200 mg/kg. Observations over 28 days showed that all mice remained healthy, alert, agile, and showed normal feeding and defecation behaviors, with no deaths recorded in any group. Those data indicated that mangiferin and HPTR are safe to use for a long time.
Hematological parameters include characteristics of red blood cells (RBC), white blood cells (WBC), platelets (PLT), hemoglobin (Hb), hematocrit (HCT), mean corpuscular volume (MCV), and mean corpuscular hemoglobin (MCH). The results from Table
In this study, the test results from Table
In order to more directly assess the impact of the test sample on the liver, after the experiment was conducted, the mice were dissected to observe the liver grossly and store samples for histological staining. Gross observation (Fig.
The biochemical serum test results from Table
In summary, the subchronic toxicity study results in this research show that the HPTR and mangiferin at a dose of 200 mg/kg did not cause toxicity in mice after 28 days of administration. Currently, there are many studies on the toxicity of mangiferin worldwide. The study by Yalena
Tyloxapol (Triton WR-1339) is a surfactant that inhibits lipoprotein lipase, with the advantages of being quick, time and cost-saving to conduct research on many groups. The model chosen in this study is the induction of endogenous lipid disorders using a dose of 400 mg/kg of tyloxapol injected intraperitoneally (
Based on the lipid blood test results from our study, the tyloxapol group after 24 hours of tyloxapol injection induced a typical change in all four blood lipid parameters: triglycerides, total cholesterol, HDL-c, and LDL-c. Specifically, the tyloxapol group showed a 25.72-fold increase in triglyceride levels, a 4.45-fold increase in total cholesterol, and a 38.59-fold increase in LDL-c compared to the control group, while the HDL-c level of the tyloxapol group decreased by 5.67 times, with all differences being statistically significant (p < 0.05). Thus, the model induced by tyloxapol is successful and reliable. The therapeutic effect of HPTR and mangiferin after 24 hours of tyloxapol injection can be based on all four parameters: triglyceride levels, total cholesterol levels, HDL-c, and LDL-c concentrations.
When evaluating the effect of blood lipid-lowering, statins are the first choice of drugs, used alone or in combination with other drugs to achieve treatment goals or when the patient is intolerant. Atorvastatin is a popular and typical drug of the statin group, proven to treat hyperlipidemia since 1987. The mechanism of atorvastatin, and statins in general, is to inhibit cholesterol synthesis in the liver, increase the number of LDL-c receptors to help bring LDL-c into the cell, and lower triglycerides by increasing the excretion of VLDL-c. Atorvastatin was chosen as a positive control because of its advantages such as having a long half-life and not being affected by food; most importantly, it can reduce LDL-c by about 34–54% depending on the dose from 10–80 mg. This effect is second only to rosuvastatin at the maximum dose of 40 mg. Moreover, atorvastatin is quite popular due to its affordability and accessibility, and can be a preferred choice for patients with renal failure.
The lipid blood test results in the study showed that the atorvastatin control group only showed a decrease in triglycerides, total cholesterol, and LDL-c compared to the tyloxapol group. However, only the levels of triglycerides and total cholesterol were statistically significant (p < 0.05), while the HDL-c parameter improved but was not statistically significant (p > 0.05).
Both mangiferin and HPTR at a dose of 200 mg/kg showed a positive effect of enhancing blood lipid parameters. The results drew a comparison that the HPTR seemed to be more effective in decreasing total cholesterol, triglycerides, LDL-c levels and increasing HDL-c level than the mangiferin to some extent, though the differences between these two groups were not statistically significant.
When comparing the results of blood lipid regulation of the HPTR and mangiferin with some other medicinal studies, the HPTR and mangiferin showed promising results. The study by Shiv Vardan Singh (2016) on mice with endogenous hyperlipidemia induced by tyloxapol at a dose of 400 mg/kg reported that the hydro-methanolic extract of Flacourtia indica at a dose of 150 mg/kg reduced total cholesterol by 17%, triglycerides by 13%, and LDL-c by 22%, and increased HDL-c by 15% compared to the tyloxapol group (
It can be seen that both atorvastatin and the high dose of 200 mg/kg did not significantly improve the HDL-c parameter, possibly because the dosage used was still not sufficient to have a significant effect in increasing HDL-c. Therefore, if we only evaluate the effect of controlling hyperlipidemia through the remaining three parameters, it is clear that HPTR at a dose of 200 mg/kg is the most promising, having a better impact in reducing triglycerides, total cholesterol, and LDL-c than the mangiferin at 200 mg/kg and equivalent to atorvastatin group. Thus, the effect of HPTR in controlling blood lipid disorders is improved compared to the mangiferin.
Our findings were consistent with the study of Sandoval-Gallegos et al., which investigated the antihyperlipidemic effect of Mangifera indica leaf extract containing mainly mangiferin on high cholesterol diet-fed mice. Their study showed that, at doses of 100, 200 and 400 mg/kg, M. indica leaf extract helped reduce total cholesterol and triglycerides levels significantly (
From these results, it can be concluded that the HPTR and mangiferin have the ability to control hyperlipidemia in mice caused by tyloxapol, with various mechanisms for reducing blood lipids such as the ability to regulate the reduction of proteins controlling the De novo lipogenesis (DNL) process as studied by Jihyeon Lim and colleagues (2014) (
In conclusion, our study successfully extracted mangiferin using the ultrasonic method and prepared a solid dispersion (HPTR) to increase the solubility of mangiferin, yet maintained its effect to control hyperlipidemia in mice caused by tyloxapol. HPTR seemed to be more effective in decreasing total cholesterol, triglycerides, LDL-c levels and increasing HDL-c level than mangiferin to some extent, though the differences between these two groups were not statistically significant.
D.T.M.H: First author: Methodology, Conceptualization, Writing – original draft, Project administration, Resources, Writing – Review & editing, Supervision; L.M.L., L.T.N., T.H.N.N., M.H.N, K.T.V.N., K.Q.T., T.L.Q.T.: Methodology, Conceptualization, Writing – original draft; M.N.T.L: Methodology, Conceptualization, Resources; H.N.M: Corresponding author: Writing – original draft, Data curation, Resources, Writing – Review & editing.
The authors have declared that no competing interests exist.
The authors would like to acknowledge the Can Tho University of Medical and Pharmacy for research support.